PTX3 and ST Elevation Myocardial Infarction: The rs2305619 AA of pentraxin 3 (PTX3), involved in inflammation, was associated with a higher incidence of microvascular obstruction in ST-elevation myocardial infarction patients after primary percutaneous coronary intervention and a higher 30-day mortality.40